Welcome to Shanghai International Medical Equipment Exhibition 2027!
Media Center
Home >> Media Center >> Industry News >> View Details
Media Center
Industry News

NeuCyber NeuroTech (Beijing) focuses on the R&D and clinical translation of brain-computer interface (BCI) technologies

Time:2026-9-22 11:10:19Hits:

NeuCyber NeuroTech (Beijing) Co., Ltd . (abbreviated as ""NeuCyber"") is an independent legalentity approved by the Beijing Municipal Government . Registered in March 2023, the companyfocuses on the R&D and clinical translation of brain-computer interface (BCI) technologies . Itcarries out in-depth cooperation with top institutions including the Beijing Institute of BrainScience and Brain-Inspired Intelligence Technology . Keeping pace with global cutting-edgedevelopments, the company develops self-controllable core BCI components and neuralencoding and decoding algorithms, and develops products for clinical application, cutting-edgebrain science research and other scenarios to drive commercial translation .

In line with Beijing’s forward-looking strategic layout, the Beijing Institute of Brain Science andBrain-Inspired Intelligence Technology has led the planning of the ""Brain-Computer SystemEnhancement Initiative"" and facilitated the establishment of NeuCyber NeuroTech (Beijing)Co., Ltd . Targeting the global frontier of high-throughput fully implantable brain-computerinterface technologies, the company independently develops core components and conductsmulti-dimensional integrated development of BCI systems . It has developed two world-leadingintelligent brain-computer systems, the semi-invasive ""North Brain No.1"" and the invasive""North Brain No.2"", continuously achieving major breakthroughs in the field .

Visitor Registration Exhibitor Login